This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Cheer Global Limited, Vision Global Holdings Limited. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Sui-Yi Kwok: Innovator in Hemoglobin-based Therapeutics
Introduction
Sui-Yi Kwok is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer treatment through his innovative research and development of hemoglobin-based therapeutic agents. With a total of 2 patents, Kwok's work is paving the way for new pharmaceutical compositions and methods of treatment.
Latest Patents
Kwok's latest patents include groundbreaking inventions. The first patent focuses on hemoglobin-based therapeutic agents that are useful for treating cancer. This patent also details pharmaceutical compositions that incorporate these agents, along with methods of use and preparation. The second patent involves mertansine polypeptide conjugates, which are also aimed at cancer treatment. This invention highlights highly N-terminal selective methods capable of yielding N-terminal mertansine conjugated polypeptides with site selectivity of 99% or greater.
Career Highlights
Throughout his career, Sui-Yi Kwok has worked with notable companies such as Cheer Global Limited and Vision Global Holdings Limited. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Kwok has collaborated with esteemed colleagues, including Norman Fung-Man Wai and Lan Zou. These partnerships have further enhanced his research and development efforts in the field of cancer therapeutics.
Conclusion
Sui-Yi Kwok is a distinguished inventor whose work in hemoglobin-based therapeutic agents and mertansine polypeptide conjugates is making a significant impact in cancer treatment. His innovative contributions and collaborations continue to advance the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile